首页> 外文会议>International Conference on Computer Science, Applied Mathematics and Applications >Molecular Screening of Azurin-Like Anticancer Bacteriocins from Human Gut Microflora Using Bioinformatics
【24h】

Molecular Screening of Azurin-Like Anticancer Bacteriocins from Human Gut Microflora Using Bioinformatics

机译:使用生物信息学,来自人肠道微生物群的紫红素样抗癌菌的分子筛选

获取原文

摘要

There has been renewed interest in the development of new cancer therapeutic drugs based on the use of live bacteria and their purified products. Bacteriocins are antimicrobial peptides produced by bacteria to inhibit the growth of closely related bacterial strains, and sometimes against a wide spectrum of species. As one of few known anticancer bacteriocins, Azurin can specifically penetrate human cancer cells and exerts cytostatic and apoptotic effects. We hypothesized that pathogenic and commensal bacteria with long term residence in human body can produce Azurin-like bacteriocins as a weapon against the invasion of cancers. Putative bacteriocins were screened from complete genomes of 66 dominant bacteria species in human gut microbiota using Bagel database and subsequently characterized by subjecting them as functional annotation algorithms using Prot fun2.2, Kihara Bioinformatics and BaCelLo with Azurin as control. The prediction of functional characterization including cell envelope activity, enzymatic activity, immune response, the number of protein phosphorylation sites and localization within the cell revealed that 14 bacteriocins possessed functional properties very similar to those of Azurin. This is first study on genomic-scale screening of anticancer bacteriocins from all dominant bacteria species in human gut microbiota.
机译:目前已经在基础上,利用活细菌及其纯化产品的新的癌症治疗药物的开发新的兴趣。细菌素是由细菌产生抑制密切相关的细菌菌株的生长的抗微生物肽,有时针对物种的宽光谱。尽可能少的已知的抗癌细菌素之一,天青蛋白可以特异性穿透人体癌细胞和施加细胞抑制和细胞凋亡作用。我们推测,致病性和共生细菌与人体长期居留可产生阿苏林样细菌对抗癌症的侵袭武器。推定的细菌素从使用百吉数据库在人类肠道菌群66个优势菌物种完整基因组筛选,随后通过将它们作为使用普罗特fun2.2,木原生物信息学和BaCelLo与天青蛋白作为对照功能注释算法表征。功能表征包括细胞包膜活性,酶活性,免疫应答的预测,在小区内蛋白质磷酸化位点和本地化数显示,14种细菌素具有功能性质非常相似天青蛋白的。这是从人类肠道菌群的所有优势菌种抗癌细菌的基因组规模筛选第一项研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号